Prospective Natural History Study of Retinitis Pigmentosa
NCT ID: NCT04285398
Last Updated: 2025-05-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
82 participants
INTERVENTIONAL
2020-02-12
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Retrospective Natural History Study of Retinitis Pigmentosa
NCT03975543
A Natural History Study to Evaluate Functional and Anatomical Progression in Retinitis Pigmentosa
NCT04558983
Sparing of the Fovea in Geographic Atrophy Progression
NCT02332343
A Prospective, Observational Study in Adults With Retinitis Pigmentosa (RP)
NCT06517940
Retinitis Pigmentosa Clinical Measures and Repeatability Testing of Potential Outcome Measures
NCT03845218
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study Group 1
Four years follow up of patients with ophthalmic examination.
Ophthalmic examinations
Slit-lamp examination, IntraOcular Pressure, Visual Acuity, Visual Field, Full-field Stimulus Threshold, Dark adaptometry, Color Vision testing, Optical Coherence Tomography, Fundus AutoFluorescence and Adaptive Optics imaging.
Study Group 2
Four years follow-up of patients with ophthalmic examination and mobility testing.
Ophthalmic examinations
Slit-lamp examination, IntraOcular Pressure, Visual Acuity, Visual Field, Full-field Stimulus Threshold, Dark adaptometry, Color Vision testing, Optical Coherence Tomography, Fundus AutoFluorescence and Adaptive Optics imaging.
Mobility Test
Functional test to evaluate mobility and postural condition of patients
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ophthalmic examinations
Slit-lamp examination, IntraOcular Pressure, Visual Acuity, Visual Field, Full-field Stimulus Threshold, Dark adaptometry, Color Vision testing, Optical Coherence Tomography, Fundus AutoFluorescence and Adaptive Optics imaging.
Mobility Test
Functional test to evaluate mobility and postural condition of patients
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Visual acuity ≥ 20/200 for at least one eye at inclusion visit
* Binocular Visual field diameter ≥ 5° as measured on the Goldmann III-4e isopter at inclusion visit
* Patients having signed the informed consent form
* Sufficient knowledge of the local language to ensure understanding of the tasks to be performed and the instructions received
* Patient affiliated to a Health Security System if they are included in a clinical site based in France (per law)
Exclusion Criteria
* Patients with other ocular disorder likely to impact the retinal function
* Pregnant or breastfeeding women
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
SparingVision
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Isabelle Audo, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
CHNO XV-XX Paris - CIC 1423
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UPMC Eye Center
Pittsburgh, Pennsylvania, United States
CHNO XV-XX Paris - CIC 1423
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PHENOROD2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.